1027775-28-5

Basic information

• Product Name: 1-Pyrrolidinecarboxylic acid, 2-Methyl-4-oxo-, 1,1-diMethylethyl ester, (2R)-
• Synonyms: 1-Pyrrolidinecarboxylic acid, 2-Methyl-4-oxo-, 1,1-diMethylethyl ester, (2R)-;(R)-tert-butyl 2-Methyl-4-oxopyrrolidine-1-carboxylate
• CAS NO: 1027775-28-5
• Molecular Formula: C10H17NO3
• Molecular Weight: 199.24688
• Mol File: 1027775-28-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 279.9±33.0 °C(Predicted)
• Appearance: /
• Density: 1.086±0.06 g/cm3(Predicted)
• PKA: -1.72±0.40(Predicted)
• CAS DataBase Reference: 1-Pyrrolidinecarboxylic acid, 2-Methyl-4-oxo-, 1,1-diMethylethyl ester, (2R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pyrrolidinecarboxylic acid, 2-Methyl-4-oxo-, 1,1-diMethylethyl ester, (2R)-(1027775-28-5)
• EPA Substance Registry System: 1-Pyrrolidinecarboxylic acid, 2-Methyl-4-oxo-, 1,1-diMethylethyl ester, (2R)-(1027775-28-5)

Safety Data

• RIDADR: UN2811
• Hazardous Substances Data: 1027775-28-5(Hazardous Substances Data)

Usage

General Description

1-Pyrrolidinecarboxylic acid, 2-methyl-4-oxo-, 1,1-dimethylethyl ester, (2R)- is a chemical compound that belongs to the class of pyrrolidine carboxylic acids. It is also known as N-Acetyl-L-proline t-butyl ester. This chemical is commonly used in organic synthesis and pharmaceutical research as a reagent and intermediate. It has potential applications in the development of new drug molecules due to its unique chemical structure and properties. Additionally, this compound is used in the preparation of various pharmaceuticals and agrochemicals for the treatment of various diseases and the improvement of crop yield.

Upstream product

• 23770-07-2 (+,)-N-benzyl-5-methylpyrrolidin-3-one 
• 24424-99-5 di-tert-butyl dicarbonate 
• 897046-42-3 1-[(1,1-dimethylethoxy)-carbonyl]-4-hydroxy-2-pyrrolidine carboxylic acid methyl ester 
• 156865-72-4 tert-butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate 
• 158851-30-0 (S)-3-tert-butoxycarbonylaminobutyric acid 
• 114676-91-4 1-tert-butyl 2-methyl (2S,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}pyrrolidine-1,2-dicarboxylate 
• 114676-58-3 (2R,4R)-tert-butyl 4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate 
• 114676-92-5 (2S,4R)-1-(tert-butoxycarbonyl)-4-<(tert-butyldimethylsilyl)oxy>-2-<<(methylsulfonyl)oxy>methyl>pyrrolidine 
• 213699-41-3 tert-butyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)-2-methylpyrrolidine-1-carboxylate 
• 114676-61-8 tert-butyl (2S,4R)-4-hydroxyl-2-methylpyrrolidine-1-carboxylate 
• 114676-93-6 (2R,4R)-tert-butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate 

Downstream Products

• 1584148-14-0 N-((R)-1-(3-chlorophenyl)ethyl)-5-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxamide 

Relevant articles and documents

Tetrahydropyrrolopyrazoles derivatives Preparation method and application thereof in medicine

The invention relates to tetrahydropyrrolopyrazol derivatives, a preparation method and an application thereof in medicine. , The present disclosure relates to a tetrahydropyrrolopyrazol derivative represented by the general formula (I), a preparation method thereof, and a use of the derivative-containing pharmaceutical composition and as a therapeutic agent, in particular as AKT1 T1 T1 T1 AKT pan T1 inhibitors and use thereof in the preparation of a medicament for the treatment and/or prevention of tumors.

FXR RECEPTOR MODULATOR, PREPARATION METHOD THEREFOR, AND USES THEREOF

The present disclosure disclosed a modulator of FXR receptor and preparation and use thereof, which relates to the technical filed of medicinal chemistry. The present disclosure provides a modulator of FXR receptor having a structural formula I or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, which can combine with FXR receptor (that is NR1H4) and be acted as a FXR agonist or a partial agonist for preventing and treating the disease mediated by FXR, such as chronic intrahepatic or extrahepatic cholestasis, hepatic fibrosis caused by chronic cholestasis or acute intrahepatic cholestasis, chronic hepatitis B, gallstone, hepatic carcinoma, colon cancer or intestinal inflammatory disease, etc. Specifically, for some chemical compounds, their EC50 for FXR agonist activity reach below 100nM, which show an excellent FXR agonist activity and an excellent prospect to provide a new pharmaceutical selection in clinical treatment for the disease mediated by FXR.

BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS

The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1 ), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and diabetes.